Foamix acne drug meets main goals in late-stage trial, shares surge

Foamix Pharmaceuticals Ltd said on Tuesday that its lead drug treating moderate-to-severe acne met the main goals of its third late-stage study, sending its shares up 57 percent in extended trading.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Acne | Health | Study